TPTX
Turning Point Therapeutics, Inc. Common Stock
TPTX
TPTX
Delisted
TPTX was delisted on the 16th of August, 2022.
208 hedge funds and large institutions have $3.06B invested in Turning Point Therapeutics, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 94 funds opening new positions, 44 increasing their positions, 61 reducing their positions, and 38 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
28% less repeat investments, than reductions
Existing positions increased: 44 | Existing positions reduced: 61
59% less call options, than puts
Call options by funds: $16.7M | Put options by funds: $40.9M
Holders
208
Holding in Top 10
10
Calls
$16.7M
Puts
$40.9M
Top Buyers
| 1 | +$87.6M | |
| 2 | +$87.3M | |
| 3 | +$77.4M | |
| 4 |
SFM
Soros Fund Management
New York
|
+$61.8M |
| 5 |
UOC
UBS O'Connor
Chicago,
Illinois
|
+$58.3M |
Top Sellers
| 1 | -$226M | |
| 2 | -$160M | |
| 3 | -$124M | |
| 4 |
PAMS
Pictet Asset Management (Switzerland)
Geneva 73,
Switzerland
|
-$117M |
| 5 |
State Street
Boston,
Massachusetts
|
-$111M |
